The influence of mitochondrial KATP-channels in the cardioprotection of preconditioning and postconditioning by sevoflurane in the rat in vivo

Anesthesia and Analgesia

Volumn 101, Issue 5, 2005, Pages 1252-1260

  Obal, Detlef ^a   Dettwiler, Saskia ^a   Favoccia, Christian ^a   Scharbatke, Horst ^a   Preckel, Benedikt ^a   Schlack, Wolfgang ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYDECANOIC ACID; INHALATION ANESTHETIC AGENT; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; SEVOFLURANE; TRIPHENYLTETRAZOLIUM; ADENOSINE TRIPHOSPHATE; ETHER DERIVATIVE; PHOSPHATIDYLINOSITOL 3 KINASE; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; IN VIVO STUDY; MALE; MINIMUM LUNG ALVEOLUS CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; ANIMAL; HEART LEFT VENTRICLE FUNCTION; PHYSIOLOGY; VASCULAR RESISTANCE; WISTAR RAT;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADENOSINE TRIPHOSPHATE; ANESTHETICS, INHALATION; ANIMALS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; METHYL ETHERS; MYOCARDIAL REPERFUSION INJURY; POTASSIUM CHANNELS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; VASCULAR RESISTANCE; VENTRICULAR FUNCTION, LEFT;

EID: 27444447883     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000181336.96511.32     Document Type: Article

References (50)

1. Toller WG, Kersten JR, Pagel PS, et al. Sevoflurane reduces myocardial infarct size and decreases the time threshold for ischemic preconditioning in dogs. Anesthesiology 1999;91:1437-46.
2. + channels and their role in cardioprotection. Circ Res 2004;94:420-32.
3. Zhao ZQ, Corvera JS, Halkos ME, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003;285:H579-88.
4. Schlack W, Preckel B, Stunneck D, Thämer V. Effect of halothane, enflurane, isoflurane, sevoflurane and desflurane on myocardial reperfusion injury in the isolated rat heart. Br J Anaesth 1998;81:913-9.
5. Obal D, Preckel B, Scharbatke H, et al. One MAC of sevoflurane provides protection against reperfusion injury in the rat heart in vivo. Br J Anaesth 2001;87:905-11.
6. Obal D, Scharbatke H, Barthel H, et al. Cardioprotection against reperfusion injury is maximal with only two minutes of sevoflurane administration in rats. Can J Anaesth 2003;50:940-5.
7. Conzen PF, Vollmar B, Habazettl H, et al. Systemic and regional hemodynamics of isoflurane and sevoflurane in rats. Anesth Analg 1992;74:79-88.
8. 2+ responses in intact hearts. Am J Physiol Heart Circ Physiol 2001;281:H1508-23.
9. Riess ML, Kevin LG, Amadou C, et al. Dual exposure to sevoflurane improves anesthetic preconditioning in intact hearts. Anesthesiology 2004;100:569-74.
10. Sandhu R, Diaz RJ, Mao GD, Wilson GJ. Ischemic preconditioning: differences in protection and susceptibility to blockade with single-cycle versus multicycle transient ischemia. Circulation 1997;96:984-95.
11. Chiari PC, Bienengraeber MW, Pagel PS, et al. Isoflurane protects against myocardial infarction during early reperfusion by activation of phosphatidylinositol-3-kinase signal transduction: evidence for anesthetic-induced postconditioning in rabbits. Anesthesiology 2005;102:102-9.
12. Tarnow J, Markschies Hornung A, Schulte Sasse U. Isoflurane improves the tolerance to pacing-induced myocardial ischemia. Anesthesiology 1986;64:147-56.
13. Cope DK, Impastato WK, Cohen MV, Downey JM. Volatile anesthetics protect the ischemic rabbit myocardium from infarction. Anesthesiology 1997;86:699-709.
14. ATP channel: reduction of myocardial infarct size with an acute memory phase. Anesthesiology 1997;87:361-70.
15. Cason BA, Gamperl AK, Slocum RE, Mickey RF. Anesthetic-induced preconditioning: previous administration of isoflurane decreases myocardial infarct size in rabbits. Anesthesiology 1997;87:1182-90.
16. Preckel B, Schlack W, Comfère T, et al. Effects of enflurane, isoflurane, sevoflurane and desflurane on reperfusion injury after regional myocardial ischaemia in the rabbit heart in vivo. Br J Anaesth 1998;81:905-12.
17. Tsang A, Hausenloy DJ, Mocanu MM, Yellon DM. Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ Res 2004;95:230-2.
18. + channels: possible mechanism of cardioprotection. Circ Res 1997;81:1072-82.
19. ATP channel in preservation of mitochondrial function. Am J Physiol Heart Circ Physiol 2000;278:H305-12.
20. ATP channels in preconditioning. Circ Res 2000;87:845-55.
21. ATP channels triggers the preconditioned state by generating free radicals. Circ Res 2000;87:460-6.
22. Müllenheim J, Ebel D, Fräßdorf J, et al. Isoflurane preconditions myocardium against infarction via release of free radicals. Anesthesiology 2002;96:934-40.
23. Novalija E, Varadarajan SG, Camara AK, et al. Anesthetic preconditioning: triggering role of reactive oxygen and nitrogen species in isolated hearts. Am J Physiol Heart Circ Physiol 2002;283:H44-52.
24. Kevin LG, Novalija E, Riess ML, et al. Sevoflurane exposure generates superoxide but leads to decreased superoxide during ischemia and reperfusion in isolated hearts. Anesth Analg 2003;96:949-55.
25. + channel of heart mitochondria. Am J Physiol Heart Circ Physiol 2001;280:H649.
26. Stowe DF, Riess ML. Reactive oxygen species and cardiac preconditioning: many questions remain. Cardiovasc Drugs Ther 2004;18:87-90.
27. Stowe DF, Kevin LG. Cardiac preconditioning by volatile anesthetic agents: a defining role for altered mitochondrial bioenergetics. Antioxid Redox Signal 2004;6:439-48.
28. ATP channel. Anesthesiology 2002;97:57-65.
29. Gassmayr S, Stadnicka A, Suzuki A, et al. Isoflurane sensitizes the cardiac sarcolemmal adenosine triphosphate-sensitive potassium channel to pinacidil. Anesthesiology 2003;98:114-20.
30. ATP channels and prostaglandin pathways. Eur J Anaesthesiol 2001;18:219-30.
31. ATP channels via multiple signaling pathways. Anesthesiology 2002;97:4-14.
32. ATP channel occurs downstream of PKC-e activation in the mechanism of preconditioning. Am J Physiol Heart Circ Physiol 2002;283:H440-7.
33. Kohro S, Hogan QH, Nakae Y, et al. Anesthetic effects on mitochondrial ATP-sensitive K channel. Anesthesiology 2001;95:1435-40.
34. Ferrari R. The role of mitochondria in ischemic heart disease. J Cardiovasc Pharmacol 1996;28 Suppl 1:51-10.
35. Riess ML, Camara AK, Chen Q, et al. Altered NADH and improved function by anesthetic and ischemic preconditioning in guinea pig intact hearts. Am J Physiol Heart Circ Physiol 2002;283:H53-60.
36. + channels by protein kinase C. Circ Res 1998;83:110-4.
37. Heindl B, Reichle FM, Zahler S, et al. Sevoflurane and isoflurane protect the reperfused guinea pig heart by reducing postischemic adhesion of polymorphonuclear neutrophils. Anesthesiology 1999;91:521-30.
38. Siegmund B, Schlack W, Ladilov YV, et al. Halothane protects cardiomyocytes against reoxygenation-induced hypercontracture. Circulation 1997;96:4372-9.
39. Inagaki K, Chen L, Ikeno F, et al. Inhibition of d-protein kinase C protects against reperfusion injury of the ischemic heart in vivo. Circulation 2003;108:2304-7.
40. 2+ loading in intact hearts. Anesthesiology 2002;96:125-33.
41. ATP channels in preconditioning. J Mol Cell Cardiol 2003;35:569-75.
42. Zweier JL, Flaherty JT, Weisfeldt ML. Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci U S A 1987;84:1404-7.
43. Becker LB. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res 2004;61:461-70.
44. Ozcan C, Bienengraeber M, Dzeja PP, Terzic A. Potassium channel openers protect cardiac mitochondria by attenuating oxidant stress at reoxygenation. Am J Physiol Heart Circ Physiol 2002;282:H531-9.
45. Haelewyn B, Zhu L, Hanouz JL, et al. Cardioprotective effects of desflurane: effect of timing and duration of administration in rat myocardium. Br J Anaesth 2004;92:552-7.
46. Hanley PJ, Gopalan KV, Lareau RA, et al. β-oxidation of 5-hydroxydecanoate, a putative blocker of mitochondrial ATP-sensitive potassium channels. J Physiol 2003;547:387-93.
47. Hanley PJ, Drose S, Brandt U, et al. 5-Hydroxydecanoate is metabolized in mitochondria and creates a rate-limiting bottle-neck for β-oxidation of fatty acids. J Physiol 2005;562:307-18.
48. Liu Y, Sato T, Seharaseyon J, et al. Mitochondrial ATP-dependent potassium channels: viable candidate effectors of ischemic preconditioning. Ann N Y Acad Sci 1999;874:27-37.
49. Akao M, Ohler A, O'Rourke B, Marban E. Mitochondrial ATP-sensitive potassium channels inhibit apoptosis induced by oxidative stress in cardiac cells. Circ Res 2001;88:1267-75.
50. De Hert SG. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology 2004;101:299-310.